𝔖 Bobbio Scriptorium

✦ LIBER ✦

Secukinumab safety in subjects with moderate to severe plaque psoriasis: A pooled analysis of neutropenia from 10 clinical studies

Book ID: 122217800
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 47 KB
Volume: 70
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2014.01.779

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Secukinumab safety and tolerability in s

Secukinumab safety and tolerability in subjects with moderate to severe plaque psoriasis: A pooled subgroup analysis of 10 clinical studies evaluating exacerbation of Crohn’s disease

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Secukinumab efficacy in subjects with mo

Secukinumab efficacy in subjects with moderate to severe plaque psoriasis: Pooled subgroup analyses by patient age of 4 phase 3 clinical studies

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Secukinumab sustainability of response i

Secukinumab sustainability of response in subjects with moderate to severe plaque psoriasis: A subanalysis from the FIXTURE study

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Secukinumab efficacy in subjects with mo

Secukinumab efficacy in subjects with moderate to severe plaque psoriasis: A pooled analysis of patient-reported symptoms (pruritus, pain, and scaling) in 2 phase 3 clinical studies (ERASURE and FIXTURE)

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Secukinumab efficacy and safety in subje

Secukinumab efficacy and safety in subjects with moderate to severe plaque psoriasis: Results from the Judging the efficacy of secUkinumab in patients with psoriasis using autoiNjector: a Clinical Trial evalUating treatment REsults trial (JUNCTURE)

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Secukinumab efficacy in subjects with mo

Secukinumab efficacy in subjects with moderate-to-severe plaque psoriasis and concomitant psoriatic arthritis: A subanalysis of the ERASURE study

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 52 KB